LITTLE FALLS, N.J.,
Oct. 16, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that
its Board of Directors approved an increase in its semiannual cash
dividend from $0.037 to $0.045 per outstanding share of the Company's
Common Stock. The dividend is payable on January 31, 2014 to shareholders of record at the
close of business on January 17,
2014.
Charles M. Diker, Chairman of the
Board, said, "We are pleased to announce the dividend increase,
which will raise our annual dividend payment from $0.074 to $0.09 per
share. The increase demonstrates Cantel's strong financial position
and our confidence in Cantel's future performance."
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products, and specialty
packaging for infectious and biological specimens. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.